David, C <br/><br/>
Soluble CD163 is a biomarker for accelerated atherosclerosis in systemic lupus erythematosus patients at apparent low risk for cardiovascular disease.  [electronic resource] 

 -  Scandinavian journal of rheumatology  Jan 2020 
 - 33-37 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1502-7732 
<br/><br/><label>Standard No.: </label>10.1080/03009742.2019.1614213  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antigens, CD--blood<br/>Antigens, Differentiation, Myelomonocytic--blood<br/>Biomarkers--blood<br/>Cardiovascular Diseases--blood<br/>Carotid Arteries--diagnostic imaging<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Lupus Erythematosus, Systemic--blood<br/>Male<br/>Plaque, Atherosclerotic--blood<br/>ROC Curve<br/>Receptors, Cell Surface--blood<br/>Retrospective Studies<br/>Risk Factors<br/>Ultrasonography<br/>CD163 Antigen